EPO Patents = 2

Trademarks = 3

Forward Citations = 10

Loading Chart...

1 inventor (with patents filed for the assignee):

Minoru S H Ko (5 out of 12 patents)

Minoru SH Ko (0 patent)

5 patents: Sort by Forward Citations

1. 12060568 - Temperature-based transient delivery of nucleic acids and proteins to cells and tissues (2024-08-13),

2. 11421248 - Temperature-based transient delivery of nucleic acids and proteins to cells and tissues (2022-08-23),

3. 11389504 - Methods of using ZSCAN4 for rejuvenating human cells (2022-07-19),

4. 10744183 - Methods of using ZSCAN4 for rejuvenating human cells (2020-08-18),

5. 10335456 - Methods of using ZSCAN4 for rejuvenating human cells (2019-07-02),

Elixirgen Therapeutics, Inc. is a biotechnology company specializing in the development of stem cell technologies for drug discovery and regenerative medicine. With a focus on induced pluripotent stem cells (iPSCs), Elixirgen Therapeutics aims to provide innovative solutions for the pharmaceutical and healthcare industries. Their cutting-edge research and technology have the potential to revolutionize the way diseases are studied and treated.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 13 2026

5 Patents

#98 in Baltimore, MD

#729 in Maryland

#50,286 in US

Baltimore, MD, United States of America

Elixirgen Therapeutics, Inc.

Forward Citations = 10

1 inventor:

Minoru S H Ko (5 out of 12 patents)

Minoru SH Ko (0 patent)

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com